UPDATE 1-FDA declines to approve Alimera's eye drug, shares tank

Dec 23 (Reuters) - The U.S. Food and Drug Administration
declined to approve Alimera Sciences Inc's
experimental drug to treat retinal swelling in its current
form, sending the biopharmaceutical...

Source: http://feeds.reuters.com/~r/reuters/governmentfilingsNews/~3/zDYDKjic-wQ/idUSSGE6BM0C520101223

government filing filings news private news private equity equity news